Atlas Trials

An Efficacy Study of JNJ-39220675 and Pseudoephedrine in Participants With Allergic Rhinitis

Clinical trial NCT00804687 · COMPLETED

Trial details

NCT number
NCT00804687
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Allergic Rhinitis
Start date
2008-11-01
Primary completion
2009-02-01
Enrollment
53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.